A protein fragment called Ba that’s produced when the alternative complement pathway is activated is found at high levels in…
Articles by Margarida Maia, PhD
AstraZeneca’s Fasenra (benralizumab) — approved for a rare type of asthma — does no worse than Nucala (mepolizumab)…
Microscopic polyangiitis (MPA) was the most common type of ANCA-associated vasculitis (AAV) among girls and Hispanic children in a…
An approach that removes specific antibodies from a person’s blood is better than a standard, more general blood-cleaning procedure called…
People with ANCA-associated vasculitis (AAV) often face a high medication burden — managing multiple medications, also known as…
Blood levels of globulins — a group of proteins that includes antibodies — when ANCA-associated vasculitis (AAV) is diagnosed…
Treatment with Tavneos (avacopan) results in significant and clinically meaningful improvements in health-related quality of life (HRQoL) for people…
Dosing has begun in a Phase 2 clinical trial of imlifidase, an  antibody-cleaving therapy, in people with ANCA-associated vasculitis…
Developing pulmonary hypertension (PH), which occurs when pressure in the blood vessels that supply the lungs becomes too high,…
Nearly half of eosinophilic granulomatosis with polyangiitis (EGPA) patients are able to stop taking glucocorticoids after a median of nine…